Inhibition of cholesterol esterification by targeting SOAT1 blocks LD formation, and the elevated unesterified cholesterol in the ER inhibits SREBP-1-regulated lipogenesis, leading to the suppression of GBM growth. The gene discussed is SOAT1; the disease is glioblastoma.